VIPER enables cancer care teams, clinical trial sponsors and trial coordinators to immediately and automatically match patients based on the genetic profile of their cancers to the best precision therapies and oncology clinical trials. 

VIPER is a HIPAA-compliant public cloud service that accesses data “behind the firewall” at participating sites and automatically ingests data from pathology systems at the time of diagnosis, and from electronic medical records and genetic test results from top genetic testing labs globally. VIPER acts as an AI-driven screening platform for research coordinators and care teams, to find the best available clinical trials for a patients’ specific diagnosis—at the time of diagnosis.  Through workflow integration, VIPER sends real-time notifications of a patient's eligibility for available clinical trials to the entire care team in the narrow enrollment window. VIPER also provides real-time interactive dashboards with rich data mining capabilities to aggregate site and study level patient data to track key metrics and trial performance. 

The combination of VIPER’s artificial intelligence solution, workflow design, communication optimization and the research coordination services provides sponsors and research sites the best opportunity to connect the right patient, to the right trial, at the right time – it’s realization of personalized medicine.